27-Apr-2023 | Facts and Factors
According to the Facts and Factors report, the global levothyroxine sodium market size was valued at around USD 3,671 million in 2022 and is expected to grow around USD 4,598 million by 2030 with a compound annual growth rate (CAGR) of approximately 3.27% between 2023 and 2030.
Levothyroxine sodium is a wide variety of treatments that depend heavily on its effectiveness or bioavailability for the result. The administration to a person of a low-power or bioavailability drug product under conditions controlled by other products that lead to a sub-optimal response and hypothyroidism. On the other side, medicines with higher efficacy may lead to a toxic manifestation of thyroid problems, including heart arrhythmia, shortness of breath, and cardiac pain, making it important to prescribe only the right dose of sodium levothyroxine to patients with cardiovascular disease. The lowest effective levothyroxine dose should be titrated to minimize the risk of osteoporosis— a disease that is seen predominantly in women.
Browse the full “Levothyroxine sodium Market – By Type (Powder and Tablets), and By Distribution Channel (Hypermarkets, Supermarkets, Drug stores, Online stores, and Specialty stores): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2023–2030." https://www.fnfresearch.com/levothyroxine-sodium-market-by-type-powder-and-tablets-1203
Hypothyroid therapy or an underactive thyroid condition is the single largest application of sodium levothyroxine — with targets for care to correct catabolic imbalances and reverse clinical progress. According to the American Association of Clinical Endocrinologists (AACE), most people suffer from hypothyroidism among some 27 million people with various thyroid disorders— the most common cause being autoimmune thyroiditis and odine deficiency. The increase in demand for levothyroxine for the treatment of thyroid cancer, apart from the decrease in the size of the enlarged thyroid gland, may increase sales of sodium levothyroxine products over the coming years.
Owing to the rising prevalence of high blood pressure and related complications, the demand for levothyroxine is expected to expand globally. The key drivers of this market are factors such as increasing geriatric population pools, sedentary lifestyles, changing dietary habits, ease of diagnosis, and increased awareness. However, poor compliance with treatment might hinder the segment's growth over the forecast period even if this risk is greatly offset by growing awareness and improving testing methods. Tablets were the largest segment of the market in 2022 based on type. This segment is anticipated to bolster throughout the forecast period, owing to ease of use and its effectiveness as compared to power. Based on distribution channels, online sales dominated the market in 2022, the growth is primarily attributable to easy availability and high internet penetration worldwide.
North America continues to dominate the global market for levothyroxine sodium. The Asia Pacific market is expected to rise at a faster rate of growth as a result of increased awareness among people, and presence of huge population in this region and increased investment by the pharmaceutical industry.
Report Scope
Report Attribute |
Details |
Market Size in 2022 |
USD 3,671 Million |
Projected Market Size in 2030 |
USD 4,598 Million |
CAGR Growth Rate |
3.27% CAGR |
Base Year |
2022 |
Forecast Years |
2023-2030 |
Key Market Players |
Renew Life Robinson Pharma, Inc., Citrucel, Benefiber, Metamucil, Optimum Nutrition, Walgreens, BarnDad’s, SPECIES, Twinlab, Myogenix, Garden Of Life, and Others. |
Key Segment |
By Type, By Distribution Channel, By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the leading players in the global market include
Renew Life Robinson Pharma, Inc., Citrucel, Benefiber, Metamucil, Optimum Nutrition, Walgreens, BarnDad’s, SPECIES, Twinlab, Myogenix, Garden Of Life, and Others.
This report segments the Levothyroxine sodium market as follows:
By Type Segmentation Analysis
By Distribution Channel Segmentation Analysis
- Hypermarkets
- Supermarkets
- Drug stores
- Online stores
- Specialty stores
By Regional Segmentation Analysis
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
